The outbreak of COVID-19 has positively impacted the NGS market recently. Targeted sequencing (TS) has become an important routine technique in both clinical and research …
MH Dziegiel, GR Krog, AT Hansen, M Olsen… - Transfusion Medicine …, 2021 - karger.com
Background: Laboratory monitoring of mother, fetus, and newborn in hemolytic disease of fetus and newborn (HDFN) aims to guide clinicians and the immunized women to focus on …
CA Hyland, H O'Brien, RL Flower… - Transfusion and Apheresis …, 2020 - Elsevier
Anti-D immunoglobulin prophylaxis reduces the risk of RhD negative women becoming alloimmunised to the RhD antigen and is a major preventative strategy in reducing the …
AA Alshehri, DE Jackson - Transfusion Medicine Reviews, 2021 - Elsevier
Hemolytic disease of fetus and newborn (HDFN) imposes great healthcare burden being associated with maternal alloimmunization against parental-inherited fetal red blood cell …
EC McGowan, H O'Brien, ME Sarri… - British Journal of …, 2024 - Wiley Online Library
Non‐invasive prenatal tests (NIPT) to predict fetal red cell or platelet antigen status for alloimmunised women are provided for select antigens. This study reports on massively …
N Nogués - Transfusion and Apheresis Science, 2020 - Elsevier
Non-invasive fetal HPA-1a typing is a valuable tool to identify the pregnancies at risk of fetal and neonatal alloimmune thrombocytopenia (FNAIT). At present, prenatal determination of …
FB Clausen - Expert Review of Molecular Diagnostics, 2018 - Taylor & Francis
Introduction: In the fight against hemolytic disease of the fetus and newborn, pregnant RhD negative women are offered antenatal and postnatal anti-D immunoglobulin prophylaxis to …
G Daniels - Annals of Blood, 2023 - aob.amegroups.org
Predicting blood group phenotypes from DNA sequence, an alternative method to conventional blood group serology, began shortly after the molecular genetic bases of many …
Advances in prenatal/neonatal genetic screening practices and next generation sequencing (NGS) technologies have made the detection of molecular causes of pediatric diseases …